Driving pharmaceutical care

through innovation and simplicity

Activities

 We are currently involved and active in the following activities and projects
  • Pharmaceutical care project on the safe and effective use of the new generation antidiabetic drugs (DPP4-inhibitors and SGLT-2-inhibitors) in type 2 diabetes
  • Pharmaceutical care project on the safe and effective use of the new generation antithrombotic drugs (DOAC) in atrial fibrillation
  • Interactive training, e-learning and organization of scientific symposia on anticoagulation management and rheumatoïd arthritis 
  • Development of an international pharmaceutical care guideline on anticoagulation management (iPACT)

 

Current positions
  • Head of pharmaceutical care department KAVA (Royal Association of Pharmacists Antwerpen) – Belgium
  • Board member KAVA (Royal Association of Pharmacists Antwerpen) – Belgium
  • Board member of iPACT – General secretary (International Pharmacists on Anticoagulation Care Taskforce)
  • Steering committee ‘development of an international pharmaceutical care guideline on anticoagulation management’

 

Current affiliations
  • Member of Pharmaceutical Care Network Europe (PCNE)
  • Member of International Pharmacist on Anticoagulation Care Taskforce (iPACT)

Silas Rydant

Oeps: Twitter reageert niet. Wacht svp een paar minuten en ververs deze pagina.